Iconic #heartfailure trialist @FaiezZANNAD presents meta-analysis of EMPEROR-Reduced and DAPA-HF trials #CVCT2020 @FaiezZANNAD @drdargaray @lucreciamburgos @ersied727 @CVCTForum @SantosGallegoMD @rachkataria @AlexNowbar @vbluml @KevinShahMD @paomorejon






Conclusion slide by @FaiezZANNAD talk on Meta-analysis of SGLT2I (Dapagliflozin and Empagliflozin) in HFrEF